Northern California Research is conducting a study for individuals who are diagnosed with type 2 diabetes and are having difficulty controlling their blood sugar. The purpose of this study is to test an experimental drug called ORMD-0801, an orally administered formulation of insulin. This study will evaluate the safety and effectiveness of the Study Drug on blood glucose and HbA1c levels. We are looking for individuals 18 and older, diagnosed with type 2 diabetes.
This is a double-blind study, which means neither you nor the study doctor will know what medication group you will be placed into. You will be randomly assigned by chance (like rolling a dice) into 1 out of 2 different study medication groups. You have an equal chance of being in either of the medication groups.
This study is 3-4 months long and includes 11 office visits. You may be compensated up to $550.00 for your time and travel. All trial-related visits, tests, and medications will be provided to you at no cost.